Single-Cell Mapping Service for Cancer Signaling Pathway
In modern oncology drug development, identifying a target is only half the battle; understanding its precise cellular context prevents pipeline failures. Our specialized mapping platform transforms raw, heterogeneous preclinical specimens into high-resolution, cell-specific signaling maps. By delivering single-cell precision, we help your team pinpoint exactly which cellular subsets drive tumor progression, characterize complex microenvironments, and uncover hidden therapeutic escape mechanisms.
Decoding the Complexity of Cancer Signaling Pathways
Tumors are highly complex, evolving cellular ecosystems where traditional bulk transcriptomic profiling fails to capture specific cellular behaviors. Isolating individual cell populations allows researchers to identify previously hidden microenvironmental feedback loops, such as macrophage-stroma crosstalk and specialized fibroblast signaling cascades. Single-cell mapping successfully circumvents the standard molecular blender effect of bulk assays, allowing modern oncology pipelines to isolate and validate highly specific therapeutic targets. By analyzing transcriptional profiles and cellular interactions at single-cell resolution, our platform provides the biological clarity needed to map complex pathways with precision.
Comprehensive Solutions
To translate challenging tumor microenvironments into strategic opportunities, Creative Biolabs offers three core services designed to provide clear, high-resolution insights into your preclinical development candidates:
High-Resolution Transcriptomic Profiling
We execute deep transcriptomic sequencing to identify rare cell sub-populations, mapping their unique expression signatures and revealing hidden driver mechanisms that regulate tumor progression and therapy resistance in heterogeneous microenvironments.
Intercellular Interactome Reconstruction
Our advanced bioinformatic pipelines construct highly accurate ligand receptor networks, revealing precise intercellular communication coordinates that drive microenvironmental immune suppression, promote tissue remodeling, and highlight novel targetable nodes for therapeutics.
Multi-Omic Pathway Activation Mapping
We integrate surface protein epitope profiling with chromatin accessibility data to calculate precise pathway activation matrices, verifying target expression and predicting potential tissue cross-reactivity early in preclinical discovery pipelines.
Partnering with Creative Biolabs mitigates target validation risks, accelerates lead selection, and streamlines your oncology research projects.
Workflow
Our end-to-end service workflow is structured to guide your projects seamlessly from wet-lab specimen processing to actionable dry-lab biological insights.
Publication
This study integrates data from eight carcinoma types to map regulatory elements and construct peak-gene networks. It identifies cell-type-conserved epigenetic regulation and key transcription factors, such as TEAD family members. In colon cancer, tumor-specific transcription factors (TFs) drive malignant programs and are validated as potential therapeutic targets, offering insights into cancer gene regulation and clinical applications.
Fig.1 Cellular composition of eight carcinomas revealed by integrated analysis. 1
Why Choose Us?
Our proprietary low-temperature dissociation chemistry preserves the native transcriptomic state of fragile tumor populations, preventing artificial cell stress and microenvironmental degradation. By combining ultra-deep single-cell sequencing with advanced bioinformatic modeling, we reconstruct clear ligand-receptor networks and quantitative pathway activation profiles with remarkable accuracy. Our robust workflows translate complex cellular heterogeneity into highly actionable therapeutic insights, allowing drug discovery teams to streamline selection and eliminate off-target development risks early in the preclinical pipeline. Experience our scientific precision and technical excellence to fast-track your next-generation oncology therapeutics. Let us help you successfully overcome complex tumor heterogeneity, reveal hidden biological networks, and secure valuable breakthroughs.
Partnering with Creative Biolabs grants your program access to a premier multi-omic platform engineered to de-risk candidate validation.
FAQs
What makes your tissue dissociation protocol better than standard commercial kits?
Our proprietary low-temperature enzymatic method prevents artificial transcriptomic stress, preserving fragile tumor cells and maintaining high cell viability exceeding eighty-five percent for analysis.
How do you identify statistically significant cell-cell communication networks?
We run advanced ligand receptor probability models against curated molecular databases, filtering out background noise to identify highly statistically significant intercellular signaling networks with confidence.
Can you handle frozen tissue specimens, or do we have to ship fresh tissue?
We process both fresh and frozen specimens, utilizing specialized single-nucleus sequencing protocols optimized for biobanked tissues to deliver high-quality, highly reliable genomic data.
Customer Review
-
Lung Cancer Resistance
Identifying rare therapy-resistant stem-like cell states using Creative Biolabs' service in our research has significantly improved our mapping of EGFR-inhibitor resistance in NSCLC. - Dr. Al*** Jones -
TIL Profiling
Directly matching surface marker proteomics with transcriptomes using Creative Biolabs' service in our research has significantly facilitated tumor-infiltrating lymphocyte characterization in complex biopsies. - Dr. El*** Rodriguez
Related Services
To further accelerate your precision oncology drug discovery program, explore these complementary offerings:
Single Cell Metabolic Analysis Services
Creative Biolabs provides single-cell metabolic analysis, quantifying metabolic heterogeneity and spatial landscapes. We utilize advanced imaging, high-dimensional protein profiling, and functional enzyme sensing to evaluate metabolic flux and cell-specific therapeutic targets.
Learn More →Photoacoustic Tumor Imaging Service
Creative Biolabs provides photoacoustic imaging, integrating optical contrast and ultrasonic resolution for real-time tumor monitoring. We utilize custom contrast agents and microscopy analysis to evaluate angiogenesis and therapeutic response.
Learn More →How to Contact Creative Biolabs
Creative Biolabs' service bridges the gap between complex tumor heterogeneity and effective precision therapies. By combining optimized tissue dissociation, multi-omic single-cell technologies, and state-of-the-art computational interactome mapping, we provide the resolution needed to discover targetable signaling loops and advance candidates into downstream development pipelines.
Ready to unlock the single-cell pathways driving your target microenvironment? Contact our scientific team today to receive a personalized proposal.
Reference
- Tang, Xiaowei, et al. "Single-cell multi-omics analysis reveals cancer regulatory elements of transcriptional programs and clinical implications." Cell Death & Disease 16.1 (2025): 746. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.1038/s41419-025-08060-7
Download our brochure